Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update describes a combination therapy strategy to prevent resistance to anti-PD-1 therapy in metastatic ovarian ca…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluates a PARP inhibitor with or without an angiogenesis inhibitor in patients with homologous recombinat…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: CYTALUX Dose Extension Study [Phase 4]
Phase 4 dose-extension study of CYTALUX by On Target Laboratories; the trial is not yet recruiting and targets lung cancer and ovarian cance…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
This clinical trial investigates how biological, genetic, and constitutional factors, plus non-invasive monitoring, can help assess individu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologi…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro [Phase 2]
Phase 2 clinical trial in newly diagnosed stage III/IV ovarian cancer evaluating neoadjuvant carboplatin/paclitaxel/pembrolizumab followed b…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer - Phase III
Phase III international study to evaluate the reliability and validity of the QLQ-OV28 ovarian cancer quality-of-life questionnaire; current…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery [Phase 2]
Phase 2 clinical trial evaluating Radspherin in patients with primary advanced epithelial cancer and peritoneal metastasis who are homologou…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This document describes a Phase 1 trial evaluating the combination of niraparib and copanlisib in patients with recurrent endometrial, ovari…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor in combination with cisplatin and hyperthermia during interval cytoreductive surgery an…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating N-acetylcysteine (NAC) to prevent chemotherapy-related cognitive impairment in ovarian cancer pat…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors [Phase 2]
The document provides an update on a Phase 2 clinical trial sponsored by Hoffmann-La Roche evaluating biomarker-driven therapies for persist…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention [NA]
The study IGNITE-TX is a feasibility trial from MD Anderson Cancer Center to identify individuals for genetic testing and treatment across m…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members [NA]
Clinical trial evaluating energy balance interventions to increase physical activity in BRCA mutation carriers, Lynch syndrome patients, CLL…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Depression Treatment and Screening in Ovarian Cancer Patients [Phase 1]
A Phase 1 clinical trial update investigating depression treatment and screening in patients with ovarian cancer and related cancers; the st…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial of Iparomlimab/Tuvonralimab with standard chemotherapy and Olaparib in platinum-sensitive recurrent ovarian cancer; currently …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) [NA]
Medtronic MITG reports ongoing recruitment for the Hugo Robotic-Assisted Surgery System in gynecologic indications. The conditions being stu…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: BRCA Founder OutReach (BFOR) Study
The BRCA Founder OutReach (BFOR) Study sponsored by Memorial Sloan Kettering Cancer Center is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase Ib/II study evaluating LBL-024 in combination with paclitaxel for platinum-resistant ovarian ca…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer [NA]
This Memorial Sloan Kettering-led trial update describes using advanced imaging to develop an imaging-based profile of high-grade serous ova…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial [Phase 3]
This update notes an ongoing Phase 3 trial evaluating minimally invasive surgery after neoadjuvant chemotherapy for advanced ovarian, fallop…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) [Phase 3]
A Phase 3 trial (DESTINY-Ovarian01) compares trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance in H…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer [Phase 1]
A Phase 1 bioequivalence study of DWZ2501 in patients with advanced BRCA-mutated high-grade ovarian cancer is currently recruiting.